Valosin Containing Protein (VCP): A Multistep Regulator of Autophagy
- PMID: 35216053
- PMCID: PMC8878954
- DOI: 10.3390/ijms23041939
Valosin Containing Protein (VCP): A Multistep Regulator of Autophagy
Abstract
Valosin containing protein (VCP) has emerged as a central protein in the regulation of the protein quality control (PQC) system. VCP mutations are causative of multisystem proteinopathies, which include neurodegenerative diseases (NDs), and share various signs of altered proteostasis, mainly associated with autophagy malfunctioning. Autophagy is a complex multistep degradative system essential for the maintenance of cell viability, especially in post-mitotic cells as neurons and differentiated skeletal muscle cells. Interestingly, many studies concerning NDs have focused on autophagy impairment as a pathological mechanism or autophagy activity boosting to rescue the pathological phenotype. The role of VCP in autophagy has been widely debated, but recent findings have defined new mechanisms associated with VCP activity in the regulation of autophagy, showing that VCP is involved in different steps of this pathway. Here we will discuss the multiple activity of VCP in the autophagic pathway underlying its leading role either in physiological or pathological conditions. A better understanding of VCP complexes and mechanisms in regulating autophagy could define the altered mechanisms by which VCP directly or indirectly causes or modulates different human diseases and revealing possible new therapeutic approaches for NDs.
Keywords: NF-κB; TFE3; TFEB; VCP; autophagy; lysophagy; neurodegenerative disease.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
Publication types
MeSH terms
Substances
Grants and funding
- GGP14039/Telethon Foundation
- GGP19128/Telethon Foundation
- 2014-0686/Fondazione Cariplo
- 2017-0747/Fondazione Cariplo
- 2021-1544/Fondazione Cariplo
- ALS_HSPB8/Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica
- ALS_Granulopathy/Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica
- MLOpathy/Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica
- Target-RAN/Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica
- 23236/French Muscular Dystrophy Association
- piano di sviluppo UNIMI - linea B/University of Milan
- SEED 2019: #TDP-43-iPSC/University of Milan
- SEED 2019: #Gender-ALS/University of Milan
- 2015LFPNMN/Ministry of Education, Universities and Research
- 2017F2A2C5/Ministry of Education, Universities and Research
- 2020PBS5MJ/Ministry of Education, Universities and Research
- Fondo per il Finanziamento delle Attività Base di Ricerca (FFABR)/Ministry of Education, Universities and Research
- Co_ALS/Italian Medicines Agency
- TRANS_ALS, project nr. 2015-0023/Fondazione regionale per la ricerca Biomedica (FRRB)
- 01ED1601A, CureALS/EU Joint Programme-Neurodegenerative Disease Research (JPND)
LinkOut - more resources
Full Text Sources
Miscellaneous
